Biktarvy, formally known as bictegravir, is a powerful single-tablet regimen for treating HIV infection. This drug integrates three crucial antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It functions by blocking the the viral ability to replicate within the body, considerably decreasing the viral load. For many individua